Regencell Bioscience Holdings 10K Form

Sell

12

RGC
Regencell Bioscience Holdings

Last Price:

5.22

Seasonality Move:

4.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales:	$3.16B
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.78
Price / Book:	0

Profitability

EPS (TTM):	-0.36000
Net Income (TTM):	$-4.71M
Gross Margin:	$1.97B
Return on Equity:	0%
Return on Assets:	0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

The Gross Profit Margin over the past 13 years for RGC is 62.33%.
The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
The Interest Expense is 0.00% of Operating Income.
Per Share Earnings over the last 18 years have been positive in 7 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	RGC
Website:	regencellbioscience.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

RGC Technical Analysis vs Fundamental Analysis

Sell

12

Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy or a Sell?

Regencell Bioscience Holdings stock is rated a Sell
The current Regencell Bioscience Holdings [RGC] share price is $5.00. The Score for RGC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.